For 2025, Quest Diagnostics expects revenues between $10.7 billion and $10.85 billion, reported EPS in the range of $8.34 to $8.59, and adjusted EPS between $9.55 and $9.80.
CI's Q4 results reflect a decline in Individual and Family Plans customers. Management expects 2025 adjusted EPS at a minimum ...
We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...